2010
DOI: 10.1677/joe-10-0072
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory events in endometrial adenocarcinoma

Abstract: Endometrial adenocarcinoma is the most common gynaecological malignancy in western countries. Many of the established risk factors for developing endometrial cancer are associated with excess exposure to oestrogen unopposed by progesterone. These include nulliparity, late onset of the menopause, post-menopausal hormone replacement therapy and obesity. However, a number of risk factors also promote inflammation, another feature proposed to influence cancer development. The human cycling endometrium undergoes re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
99
0
4

Year Published

2011
2011
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 113 publications
(106 citation statements)
references
References 191 publications
(114 reference statements)
3
99
0
4
Order By: Relevance
“…In addition to a wealth of cell and animal experimental studies, LC ω-3 PUFAs have been shown to hold antiinflammatory properties in epidemiologic studies (11,12) and randomized clinical trials (13)(14)(15). They are further hypothesized to have chemoprotective properties for endometrial cancer (and other estrogendependent cancers), as inhibition of inflammation via NF-κB and COX-2 is associated with reduced estrogen synthesis (24)(25)(26), which is thought to be a critical component for endometrial proliferation (27,28). However, this latter hypothesized mechanism predominantly represents inhibition of estrogen signaling via aromatase, which would be expected to occur primarily among noncycling (i.e., postmenopausal) women.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to a wealth of cell and animal experimental studies, LC ω-3 PUFAs have been shown to hold antiinflammatory properties in epidemiologic studies (11,12) and randomized clinical trials (13)(14)(15). They are further hypothesized to have chemoprotective properties for endometrial cancer (and other estrogendependent cancers), as inhibition of inflammation via NF-κB and COX-2 is associated with reduced estrogen synthesis (24)(25)(26), which is thought to be a critical component for endometrial proliferation (27,28). However, this latter hypothesized mechanism predominantly represents inhibition of estrogen signaling via aromatase, which would be expected to occur primarily among noncycling (i.e., postmenopausal) women.…”
Section: Discussionmentioning
confidence: 99%
“…ИЛ-6, ИЛ-8 и ФНО-α, являясь провоспалительными цитокинами, под-держивают в организме воспалительную направленность иммунных реакций. Повышение их уровня отмечается при атеросклерозе, остеопорозе, депрессии, онкологиче-ских заболеваниях репродуктивных органов, уровень их повышения напрямую коррелирует с прогнозом течения онкологического заболевания, данные цитокины секре-тируются раковыми клетками для поддержания патологи-ческой пролиферации [15,16]. Именно поэтому при изна-чально повышенном уровне ИЛ-6 и ИЛ-8 снижение их на фоне лечения мы считаем прогностически благоприят-ным моментом.…”
Section: Discussionunclassified
“…The transforming tissues exude prostaglandins and cyclooxygenases. Irreversible malignant proliferation of the endometrium takes place (413,414).…”
Section: Ebvmentioning
confidence: 99%